Study authors assessed registry data to evaluate the risk of developing childhood chronic inflammatory diseases dependent on disease status of the parents.
Breast cancer risk in women with type 2 diabetes may be influenced by long-term metformin use, according to recent study results.
Concomitant treatment of common comorbidities of HS, including anxiety and depression, metabolic syndrome, and smoking, may improve treatment outcomes.
The researchers assessed the rate of diabetic retinopathy progression in pregnant women with type 1 diabetes and its predictors.
Researchers assessed the association between inflammatory disease activity and incident diabetes mellitus in patients with rheumatoid arthritis.
A new study confirms that the timing of meals affects cardiometabolic risk factors and the ability to lose weight.
The effects of combined verinurad and febuxostat treatment were independent of blood pressure.
Study findings suggest NSAIDs may be a risk factor for acute kidney injury and hyperkalemia in patients with diabetes.
Duration-dependent beneficial effects of metformin, sulfonylurea, and thiazolidinedione use on COPD exacerbation have been observed in patients with COPD and diabetes.
Additional safety data on testosterone therapy are needed before it can be used to prevent type 2 diabetes.
Decrease in alcohol consumption, easier diabetes control perception were factors associated with better glycemic control
Remission rates greater in younger participants and those with short diabetes duration, higher HOMA percentage B
Among noncritical hospitalized COVID-19 patients, admission hyperglycemia is an independent predictor of all-cause mortality.
Whether successful treatment of depression reduces the risk for progression needs to be determined.
An intensive lifestyle intervention was found to be associated with a significant loss of fat mass and lean mass in adults with type 2 diabetes.
Patients with chronic obstructive pulmonary disease (COPD) who have higher levels of HbA1c are at increased risk for hospital admission for acute exacerbations.
Researchers sought to identify the association between proinflammatory and hyperinsulinemic diets with type 2 diabetes risk.
Evidence suggests that a class of drugs used to treat HIV and hepatitis B can reduce a patient’s risk for developing type 2 diabetes.
The FDA approved therapies to treat pain, type 2 diabetes, hormone deficiency, and juvenile idiopathic arthritis in September 2020.
A longitudinal care model for diabetes management that puts registered nurses in charge of overseeing a proactive and personalized intervention for diabetes patients resulted in enhanced care.